Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Board & Shareholder Meetings View source PDF

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.1%1-day move

₹175.95

prior close

₹172.89

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.1+0.1+0.1+0.1+0.4-0.5+1.9+1.7-1.7-6.8-9.6+1.9—

Up moveDown movePending

AI summary

Piramal Pharma Limited has disclosed its schedule of upcoming analyst and institutional investor meetings from May 28 to June 12, 2026. The company will participate in five major investor conferences hosted by prominent financial institutions including 360 ONE Capital, Bank of America, Citi, ICICI Securities, and Goldman Sachs. All meetings are scheduled to take place in Mumbai as group or one-on-one sessions. This disclosure is made under SEBI's Regulation 30(6) of the Listing Obligations and Disclosure Requirements Regulations. The company notes that dates are subject to change due to exigencies.

Likely market impact

This is a routine regulatory disclosure with no immediate impact on the stock. However, participation in multiple high-profile investor conferences indicates active investor relations efforts and sustained interest from institutional investors in the pharma sector.